| Literature DB >> 32866803 |
S J Jenepha Mary1, Mohd Usman Mohd Siddique2, Sayantan Pradhan3, Venkatesan Jayaprakash4, C James5.
Abstract
Novel antiviral active molecule 2- [(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluoro- phenyl)acetamide has been synthesised and characterized by FT-IR and FT-Raman spectra. The equilibrium geometry, natural bond orbital calculations and vibrational assignments have been carried out using density functional B3LYP method with the 6-311G++(d,p) basis set. The complete vibrational assignments for all the vibrational modes have been supported by normal coordinate analysis, force constants and potential energy distributions. A detailed analysis of the intermolecular interactions has been performed based on the Hirshfeld surfaces. Drug likeness has been carried out based on Lipinski's rule and the absorption, distribution, metabolism, excretion and toxicity of the title molecule has been calculated. Antiviral potency of 2- [(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluoro-phenyl) acetamide has been investigated by docking against SARS-CoV-2 protein. The optimized geometry shows near-planarity between the phenyl ring and the pyrimidine ring. Differences in the geometries due to the substitution of the most electronegative fluorine atom and intermolecular contacts due to amino pyrimidine were analyzed. NBO analysis reveals the formation of two strong stable hydrogen bonded N-H···N intermolecular interactions and weak intramolecular interactions C-H···O and N-H···O. The Hirshfeld surfaces and consequently the 2D-fingerprint confirm the nature of intermolecular interactions and their quantitative contributions towards the crystal packing. The red shift in N-H stretching frequency exposed from IR substantiate the formation of N-H···N intermolecular hydrogen bond. Drug likeness and absorption, distribution, metabolism, excretion and toxicity properties analysis gives an idea about the pharmacokinetic properties of the title molecule. The binding energy -8.7 kcal/mol of the nonbonding interaction present a clear view that 2- [(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluoro- phenyl) acetamide can irreversibly interact with SARS-CoV-2 protease.Entities:
Keywords: Density functional theory; FT-IR and Raman spectra; Hirshfeld surface; Natural bond orbital analysis; SARS-CoV-2
Mesh:
Substances:
Year: 2020 PMID: 32866803 PMCID: PMC7419267 DOI: 10.1016/j.saa.2020.118825
Source DB: PubMed Journal: Spectrochim Acta A Mol Biomol Spectrosc ISSN: 1386-1425 Impact factor: 4.098
Fig. 1Optimized molecular structure of DAPF dimer at Becke three Lee–Yang–Parr/6-311++G(d,p) level of theory representing the most stable structure with minimum energy.
Optimized bond length of DAPF monomer and dimer by Becke three Lee–Yang–Parr/6-311G++(d,p) in comparison with X-ray diffraction data.
| Bond length | Monomer | Dimer | Δ(d-m) | Expt. |
|---|---|---|---|---|
| Calc/Å | Calc/Å | /Å | /Å | |
| C1–C2 | 1.387 | 1.387 | 0.000 | 1.377 |
| C1–C6 | 1.401 | 1.400 | −0.001 | 1.386 |
| C1–H7 | 1.085 | 1.085 | 0.000 | 0.930 |
| C2–C3 | 1.384 | 1.384 | 0.000 | 1.358 |
| C2–H8 | 1.082 | 1.082 | 0.000 | 0.930 |
| C3–C4 | 1.382 | 1.382 | 0.000 | 1.359 |
| C3–F9 | 1.353 | 1.352 | −0.001 | 1.360 |
| C4–C5 | 1.390 | 1.390 | 0.000 | 1.389 |
| C4–H10 | 1.083 | 1.083 | 0.000 | 0.930 |
| C5–C6 | 1.399 | 1.399 | 0.000 | 1.389 |
| C5–H11 | 1.078 | 1.078 | 0.000 | 0.930 |
| C6–N12 | 1.407 | 1.407 | 0.000 | 1.415 |
| N12–H13 | 1.018 | 1.019 | 0.001 | 0.860 |
| N12–C14 | 1.366 | 1.365 | −0.001 | 1.339 |
| C14–O15 | 1.218 | 1.218 | 0.000 | 1.223 |
| C14–C16 | 1.529 | 1.529 | 0.000 | 1.513 |
| C16–H17 | 1.087 | 1.087 | 0.000 | 0.970 |
| C16–H18 | 1.089 | 1.089 | 0.000 | 0.970 |
| C16–S19 | 1.834 | 1.833 | −0.001 | 1.805 |
| S19–C20 | 1.777 | 1.782 | 0.005 | 1.762 |
| C20–N21 | 1.325 | 1.326 | 0.001 | 1.329 |
| C20–N25 | 1.331 | 1.327 | −0.004 | 1.321 |
| N21–C22 | 1.342 | 1.354 | 0.012 | 1.359 |
| C22–C23 | 1.400 | 1.405 | 0.005 | 1.388 |
| C22–N30 | 1.364 | 1.344 | −0.020 | 1.345 |
| C23–C24 | 1.389 | 1.385 | −0.004 | 1.384 |
| C23–H26 | 1.082 | 1.082 | 0.000 | 0.930 |
| C24–N25 | 1.350 | 1.354 | 0.004 | 1.361 |
| C24–N27 | 1.374 | 1.374 | 0.000 | 1.344 |
| N27–H28 | 1.009 | 1.009 | 0.000 | 0.860 |
| N27–H29 | 1.008 | 1.008 | 0.000 | 0.860 |
| N30–H31 | 1.008 | 1.022 | 0.014 | 0.860 |
| N30–H32 | 1.006 | 1.005 | −0.001 | 0.860 |
| Inter and intramolecular distances | ||||
| N21···H63 | – | 2.029 | 2.029 | 2.291 |
| H31···N53 | – | 2.024 | 2.024 | 2.291 |
| H13···N25 | 2.034 | 0.000 | −2.034 | 2.245 |
Å- Angstrom.
Δ(d-m)- Difference in bond length between dimer and monomer molecule.
Expt - Experimental.
Second Order Perturbation Theory Analysis of Fock Matrix of DAPF dimer in NBO basis.
| Donor | Acceptor | E(2) | E(j) – E(i) | F(i,j) |
|---|---|---|---|---|
| (i) | (j) | kcal/mol | a.u | a.u |
| n3(F9) | π* (C3–C4) | 18.17 | 0.43 | 0.086 |
| n1(N12) | π* (C5–C 6) | 34.89 | 0.29 | 0.091 |
| n1(N12) | π* (C14–O15) | 63.18 | 0.28 | 0.12 |
| n2(O15) | σ* (N12–C14) | 25.17 | 0.72 | 0.122 |
| n2(O15) | σ* (C5–H11) | 1.1 | 0.73 | 0.026 |
| n2(O15) | σ* (C14–C16) | 21.16 | 0.61 | 0.103 |
| n2(S19) | σ* (C14–C16) | 5.05 | 0.61 | 0.051 |
| n2(S19) | π* (C20–N21) | 25.65 | 0.22 | 0.073 |
| n1(N21) | σ* (C20–N25) | 12.48 | 0.88 | 0.095 |
| n1(N21) | σ* (C22–N30) | 4.03 | 0.84 | 0.053 |
| n1(N25) | σ* (N12–H13) | 7.31 | 0.8 | 0.069 |
| n1(N25) | σ* (C20–N21) | 11.97 | 0.9 | 0.094 |
| n1(N25) | σ* (C23–C24) | 9.01 | 0.92 | 0.083 |
| n1(N27) | π* (C24–N25) | 39.71 | 0.29 | 0.105 |
| n1(N30) | π* (C22–C23) | 58.38 | 0.26 | 0.116 |
| From unit1 to unit 2 | ||||
| n1(N21) | σ* (N62–H63) | 10.54 | 0.8 | 0.084 |
| From unit2 to unit 1 | ||||
| n1(N53) | σ* (N30–H31) | 10.64 | 0.8 | 0.084 |
| Within unit 2 | ||||
| n1(N53) | σ* (C52 - N57) | 12.48 | 0.88 | 0.095 |
| n1(N53) | σ* (C54 - C55) | 9 | 0.88 | 0.081 |
| n1(N53) | σ* (C54 - N62) | 4.02 | 0.84 | 0.053 |
| n1(N62) | π* (C54 - C55) | 59.61 | 0.26 | 0.116 |
E(2) represents energy of the hyperconjugative interaction.
E(j) – E(i) is the energy difference between donor(i) and acceptor(j) NBO orbitals.
F(i,j) is the Fock matrix element between i and j NBO orbitals.
Occupancy of the interacting NBOS with their corresponding energies of DAPF monomer and dimer.
| Parameters | Occupancy (e) | Energy (a.u.) | ||||
|---|---|---|---|---|---|---|
| Monomer | Dimer | Δocc | Monomer | Dimer | Δ | |
| \n1(N21) | 1.89501 | 1.88287 | −0.01214 | −0.3476 | −0.36193 | −0.01433 |
| σ* (N30 – H31) | 0.00837 | 0.03613 | 0.02776 | 0.40416 | 0.43901 | 0.03485 |
| σ* (C22 – N30) | 0.03048 | 0.02634 | −0.00414 | 0.44296 | 0.48025 | 0.03729 |
| σ* (N21 – C22) | 0.02521 | 0.02732 | 0.00211 | 0.50599 | 0.48755 | −0.01844 |
| n1(N53) | 1.89509 | 1.88303 | −0.01206 | −0.3476 | −0.36232 | −0.01472 |
| 0.03281 | 0.03087 | −0.00194 | 0.5252 | 0.52014 | −0.00506 | |
| 0.00837 | 0.03583 | 0.02746 | 0.43901 | 0.43876 | −0.00025 | |
| 0.03048 | 0.02626 | −0.00422 | 0.48025 | 0.48147 | 0.00122 | |
| σ* (C22 – C23) | 0.03281 | 0.03094 | −0.00187 | 0.5252 | 0.5202 | −0.005 |
| n1(N30) | 1.78013 | 1.71749 | −0.06264 | −0.29972 | −0.26689 | 0.03283 |
Δocc difference in occupancy between dimer and monomer.
Values for monomer are taken from identical NBOs of other unit.
Composition of H-bonded NBOs in terms of natural atomic hybrids of DAPF monomer and dimer.
| NBO | Monomer | Dimer | ΔNB0 |
|---|---|---|---|
| −0.053 | |||
| % s-char | 27.040 | 31.630 | 4.590 |
| pol. N30% | 30.170 | 27.190 | −2.980 |
| pol. H31% | 69.830 | 72.810 | 2.980 |
| q(N30)/e | 0.549 | 0.521 | −0.028 |
| q(H31)/e | −0.836 | −0.853 | −0.018 |
| sp1.88 | sp1.87 | 0.01 | |
| % s-char | 34.650 | 34.720 | 0.070 |
| pol. C22% | 41.250 | 40.780 | −0.470 |
| pol. N30% | 58.750 | 59.220 | 0.470 |
| q(C22)/e | 0.642 | 0.639 | −0.004 |
| q(N30)/e | −0.767 | −0.770 | −0.003 |
Fig. 2Hirshfeld surface of DAPF mapped over dnorm region −0.382 to +1.154 a.u.
Fig. 32D Fingerprint plot of DAPF mapped over dnorm surface showing the characteristic hydrogen bonded interactions.
(a) 2D Fingerprint plot of DAPF with characteristic N···H interaction.
(b) dnorm surfaces of DAPF displaying N···H interaction.
(c) 2D Fingerprint plot of DAPF with characteristic O···H interaction.
(d) dnorm surfaces of DAPF displaying O···H interaction.
(e) Fingerprint plot of DAPF with characteristic H ···F interaction.
(f) dnorm surfaces of DAPF displaying H ···F interaction.
Vibrational assignments of DAPF dimer by normal coordinate analysis.
| νIR | νRaman | ν(scaled) | IR(I) | Raman(I) | Assignments of modes with PED≥10% |
|---|---|---|---|---|---|
| 3459s | 3549 | 29 | 70 | νasNH(Am3)(99) | |
| 3282s | 3279 | 371 | 380 | νNH(Amd)(99) | |
| 3184s | 3208 | 2993 | 2 | νssNH (Am2) (32)+ | |
| 3102w | 3112 | 6 | 44 | νCH (99) | |
| 3098s | 3078s | 3093 | 6 | 43 | νCH(99) |
| 3035w | 3045 | 6 | 162 | νCH (99) | |
| 3004s | 3014 | 5 | 80 | νCH (99) | |
| 2943m | 3005 | 0 | 71 | νMetip(95) | |
| 2944s | 2942 | 4 | 110 | νssMet(M1)(95) | |
| 1670 | 238 | 48 | νCO(67)+βCNH(Amdr1) (15) | ||
| 1658s | 1663s | 1668 | 266 | 36 | νCO(72) + βCNH(Amdr3) (11) |
| 1608s | 1619 | 1 | 13 | γNH(Am2) (42)+γNH(Am4) (42) | |
| 1602s | 1609 | 848 | 0 | γNH(Am2) (35)+γNH(Am4) (31)+νCNr2 (11) | |
| 1576m | 1572 | 28 | 101 | νCC(51)+βCCH(10)+βCNH(10) | |
| 1558s | 1564 | 150 | 13 | νCC(26)+νCN(21)+ γNH(Am2)((17) | |
| 1508s | 1544s | 1510 | 1183 | 2 | νCC(33)+νCN(19)+βCCH(10) |
| 1507 | 148 | 27 | νCN (r2) (29)+νCCr3 (29) | ||
| 1470s | 1508m | 1492 | 176 | 21 | νCC(31)+νCN(r2)((30) |
| 1479 | 305 | 33 | βCCH(r1)((54)+νCC(r1)((31) | ||
| 1460m | 1412 | 323 | 31 | βCCH(r1)((51)+νCC(r2) (34) | |
| 1403s | 1410 | 116 | 1 | νCN(r2)((33)+νCNar(30) | |
| 1406m | 1341 | 13 | 14 | νCN(r4)((35)+νCNar(r2)(28) | |
| 1302s | 1329s | 1326 | 41 | 13 | γMetM2 (90) |
| 1295 | 52 | 13 | γMetM1(86) | ||
| 1294w | 1271 | 25 | 6 | βCCH(r1)(80) | |
| 1232m | 1240m | 1237 | 6 | 10 | βCCH1(r3)(82) |
| 1190 | 4 | 7 | νCN(r2) (51)+νCC(11)+ γCNH2 (10) | ||
| 1155w | 1148 | 40 | 15 | νCN(r4) (20)+νCC(20)+Rtrd(r3 (17)+βCCH(r2) (15)+βCCH(r2) (15) | |
| 1130m | 1134 | 22 | 21 | βCCH(r1) (65)+νCC(19)+νCF(r1) (11) | |
| 1129 | 19 | 12 | βCCH(r3) (66)+νCC(r3) (16)+ νCF(r3)(8) | ||
| 1013m | 1129w | 1035 | 15 | 13 | ωCS(M2) (29)+2ωCC3(M1)((28)+νCC(10) |
| 976 | 56 | 0 | ρCNH(Am2)((27)+ ρCNH(Am1) (15)+ρ(Am4) (13)+νCC(M1) (20) | ||
| 976m | 957 | 18 | 29 | νCNar4 (45)+Rtrdr4 (37) | |
| 947 | 20 | 30 | νCNr2 (43)+Rtrdr2(42)ρ | ||
| 930w | 933m | 930 | 0 | 0 | ωCH(r1) (89) |
| 904 | 3 | 3 | νCC(r3) (34)+βCN3 (15)+βCN(Amd2) (14)+νCN(r1) (10) | ||
| 896m | 852 | 42 | 23 | νCS(M1) (24)+Rasd2' (20)+νCN(r2) (19)+νCC(r1) (15) | |
| 838m | 849w | 832 | 3 | 30 | νCC(r1) (30)+ ρMet(M1)((20)+βCN(Amd) (11) |
| 806m | 803 | 39 | 1 | ωCH(r1)(73) | |
| 791 | 17 | 7 | ωCH(r1)((46)+ ρMet(M1)((23) | ||
| 793w | 720 | 40 | 0 | 2ωCH(r1)(81) | |
| 669m | 698w | 669 | 7 | 7 | Rpuk(r2) (27)+ωCN(16)+ωCS(13) |
| 636 | 34 | 1 | 2ωMet(M1)) (32)+2ωCN(M1)(23) | ||
| 618m | 632w | 622 | 0 | 5 | Rad(r1) (52)+Rad'(r1) (22) |
| 591 | 4 | 2 | Rad'(r3) (20)+ Rad (r3) (19) | ||
| 518w | 588m | 533 | 3 | 17 | ωCS(M2) (31)+ Rad2'(M2)(15)+ νCN (r4) (10) |
| 494 | 32 | 5 | ω(Amd2) (20)+ νCS(M2)(19)+ Rad'(M2) (13) | ||
| 495w | 449 | 1 | 5 | βCN(r2) (18)+βNNr2 (16)+Rad(r2) (14) | |
| 432w | 402 | 10 | 7 | βNCC(M2) (30)+ τCC(15)+ Rad'(r2)(11) | |
| 393w | 381 | 1 | 0 | Rayt(r3) (56)+ ωCH(M2) (21)+ Rat1'(r3) (15) | |
| 362w | 326 | 5 | 3 | Rpuk(r4) (15)+ωCF(M2) (12) | |
| 322w | 298 | 7 | 4 | βNN(r2) (37)+βCN(r2) (16) | |
| 284w | 234 | 7 | 2 | βCN(r1) (32)+βCN(r3) (21)+βCF(r3) (11) | |
| 229w | 2 | 1 | τSCM2 (21)+ Rayt(r4) (19)+τCC(M2) (17) |
νIR- Frequency of Infrared.
νRaman- Frequency of Raman.
νCal –Calculated frequency.
aIIR- Infrared intensity.
bIRaman- Raman intensity.
PED- Potential energy distribution.
s: strong; m: medium; w:weak.
Symbols used: ν -stretching; νas - asymmetric stretching; νas - symmetric stretching; β – bending; ω – wagging; γ- inplane bending; γ’- outplane bending; ρ- rocking; τ- torsion; Rad- asymmetric deformation; Rad’- asymmetric deformation out of plane; Rpuk- puckering; Amd - amide; Am -amine; ip – inplane stretching; Met- methyl; M1-moleculeI; M2-moleculeII; r1- ring1; r2- ring2; r3- ring3; r4- ring4.
Fig. 4FT-IR spectrum of DAPF. (A) Experimental Fourier transform-Infrared spectra of DAPF revealing the characteristics Infrared bands in the region 4000–0 cm−1. (B) Simulated Fourier transform-Infrared spectra of DAPF revealing the characteristics Infrared bands in the region 4000 cm−1 to 400 cm−1.
Fig. 5FT-Raman spectrum of DAPF. (a) Experimental Fourier transform-Raman spectra of DAPF revealing the characteristics Raman bands in the region 4000 cm−1 to 0 cm−1. (b) Simulated Fourier transform-Raman spectra of DAPF revealing the characteristics Raman bands in the region 4000 cm−1 to 0 cm−1.
Drug likeness properties of DAPF.
| Lipinski's rule | Drug likeness properties of DAPF | Lipinski's rule satisfied (yes/no) |
|---|---|---|
| Molecular weight | 293.32 g/mol | Yes |
| Number of HB acceptors (≤10) | 4 | Yes |
| Number of HB donors (≤5) | 3 | Yes |
| Lipophilicity log P (≤5) | 1.74 | Yes |
| Molar refractivity (40 to130) | 76 | Yes |
Absorption, distribution, metabolism, excretion, toxicity (ADMET) properties of DAPF.
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-brain barrier | BBB+ | 0.9789 |
| Human intestinal absorption | HIA+ | 0.8629 |
| Caco-2 permeability | Caco2- | 0.5649 |
| P-glycoprotein substrate | Non-substrate | 0.7566 |
| P-glycoprotein inhibitor | Non-inhibitor | 0.6319 |
| Non-inhibitor | 0.9546 | |
| Renal organic cation transporter | Non-inhibitor | 0.7981 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.4296 |
| Metabolism | ||
| CYP450 2C9 substrate | Non-substrate | 0.8784 |
| CYP450 2D6 substrate | Non-substrate | 0.8302 |
| CYP450 3A4 substrate | Non-substrate | 0.6196 |
| CYP450 1A2 inhibitor | Inhibitor | 0.7502 |
| CYP450 2C9 inhibitor | Inhibitor | 0.5890 |
| CYP450 2D6 inhibitor | Non-inhibitor | 0.6972 |
| CYP450 2C19 inhibitor | Inhibitor | 0.6940 |
| CYP450 3A4 inhibitor | Inhibitor | 0.6666 |
| CYP Inhibitory promiscuity | High CYP Inhibitory Promiscuity | 0.8737 |
| Excretion | ||
| Toxicity | ||
| Human ether-a-go-go-related gene inhibition | Weak inhibitor | 0.9943 |
| Non-inhibitor | 0.7087 | |
| AMES toxicity | Non AMES toxic | 0.6974 |
| Carcinogens | Non-carcinogens | 0.8358 |
| Fish toxicity | Low FHMT | 0.8744 |
| | High TPT | 0.7894 |
| Honey bee toxicity | Low HBT | 0.8417 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute oral toxicity | III | 0.5613 |
| Carcinogenicity (three-class) | Non-required | 0.4045 |
Bond distances of DAPF and types of bond with SARS-CoV-2 main protease.
| Molecule name | Distance (Å) | Bond category | Bond type |
|---|---|---|---|
| DAPF:H - A:LEU141:O | 1.77679 | Hydrogen bond | Conventional hydrogen bond |
| A:ARG188:HA - :DAPF:F | 2.62388 | Hydrogen bond; | Carbon hydrogen bond; |
| DAPF:H - A:HIS164:O | 2.9894 | Hydrogen bond | Conventional hydrogen bond |
| A:ASP187:O - :DAPF:F | 3.16325 | Halogen | Halogen (fluorine) |
| DAPF:F - A:MET49 | 4.28188 | Hydrophobic | Alkyl |
| DAPF - A:MET49 | 4.65914 | Hydrophobic | Pi-alkyl |
| DAPF - A:CYS145 | 4.69418 | Hydrophobic | Pi-alkyl |
| A:HIS41 - :DAPF | 4.74499 | Hydrophobic | Pi-Pi stacked |
| A:MET165:SD - :DAPF | 5.50755 | Other | Pi-sulphur |
Fig. 6Comprehensive perception of main protease and DAPF after docking, (a) secondary structure of SARS-CoV-2 mainprotease represented by ribbon and DAPF represented is by ball and stick model (b) interactions of DAPF with SARS-CoV-2 main protease amino acids. Bonds are in dots. DAPF (orange) surrounding amino acids (sky blue) are in three letters code.